Insider Transactions in Q1 2025 at Genprex, Inc. (GNPX)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 18
2025
|
Ryan M. Confer President, CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
395
-1.01%
|
$0
$0.41 P/Share
|
Feb 18
2025
|
Mark Stanley Berger Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
585
-2.54%
|
$0
$0.41 P/Share
|